Burning Rock Biotech (BNR) Gross Profit (2020 - 2025)
Historic Gross Profit for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $13.9 million.
- Burning Rock Biotech's Gross Profit rose 608.19% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.6 million, marking a year-over-year increase of 1131.98%. This contributed to the annual value of $49.6 million for FY2024, which is 295.74% down from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Gross Profit is $13.9 million, which was up 608.19% from $15.1 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Gross Profit peaked at $16.5 million during Q4 2021, and registered a low of $11.0 million during Q4 2023.
- In the last 5 years, Burning Rock Biotech's Gross Profit had a median value of $13.8 million in 2022 and averaged $13.5 million.
- In the last 5 years, Burning Rock Biotech's Gross Profit skyrocketed by 2593.49% in 2021 and then tumbled by 2506.47% in 2023.
- Burning Rock Biotech's Gross Profit (Quarter) stood at $16.5 million in 2021, then fell by 11.22% to $14.7 million in 2022, then fell by 25.06% to $11.0 million in 2023, then increased by 11.35% to $12.3 million in 2024, then rose by 13.33% to $13.9 million in 2025.
- Its last three reported values are $13.9 million in Q3 2025, $15.1 million for Q2 2025, and $13.4 million during Q1 2025.